SUNPHARMA Sun Pharmaceutical Industries Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · Nifty 50 Weight: 1.66%Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about SUNPHARMA
In the last completed session, Sun Pharmaceutical Industries Ltd. closed -1.21% with futures open interest moving +0.5%. Positioning is neutral — neither side is decisively adding or unwinding right now. The option PCR of 0.76 is balanced — no clear directional preference from option writers. Max-pain strike at ₹1,820 sits 3.4% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Sun Pharmaceutical Industries Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Sun Pharmaceutical Industries Ltd. is best read as range-bound for now.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-07 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-06-24 | BUY | ₹ 1,868.00 | 28.85 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794 |
| 2026-06-24 | SELL | ₹ 1,868.00 | 28.85 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 |
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-10-27 · spot 1,781 · EOD 2026-10-07
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 137%
Δ 0.65
θ -5.6
ν 2
|
1660 | |
|
IV 174%
Δ 0.64
θ -7.1
ν 2
|
1680 | |
|
IV 34%
Δ 0.75
θ -1.4
ν 1
|
1700 |
IV 21%
Δ -0.14
θ -0.5
ν 1
|
|
IV 163%
Δ 0.61
θ -6.8
ν 2
|
1720 |
IV 21%
Δ -0.20
θ -0.6
ν 1
|
|
IV 16%
Δ 0.78
θ -0.7
ν 1
|
1740 |
IV 21%
Δ -0.28
θ -0.7
ν 1
|
|
IV 16%
Δ 0.67
θ -0.8
ν 1
|
1760 |
IV 20%
Δ -0.36
θ -0.7
ν 2
|
|
IV 17%
Δ 0.55
θ -0.9
ν 2
|
1780 S |
IV 20%
Δ -0.46
θ -0.7
ν 2
|
|
IV 17%
Δ 0.43
θ -0.8
ν 2
|
1800 |
IV 20%
Δ -0.55
θ -0.7
ν 2
|
|
IV 17%
Δ 0.33
θ -0.8
ν 1
|
1820 MP |
IV 21%
Δ -0.64
θ -0.7
ν 2
|
|
IV 18%
Δ 0.24
θ -0.7
ν 1
|
1840 |
IV 22%
Δ -0.71
θ -0.6
ν 1
|
|
IV 18%
Δ 0.17
θ -0.5
ν 1
|
1860 |
IV 23%
Δ -0.77
θ -0.5
ν 1
|
| 1880 |
IV 26%
Δ -0.79
θ -0.5
ν 1
|
|
| 1900 R |
Chain Interpretation
Strategy Builder multi-leg payoff for SUNPHARMA options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
SUNPHARMA — frequently asked questions
What is the Sun Pharmaceutical Industries Ltd. share price today?
SUNPHARMA is trading at ₹1,759.80 (-1.19% vs previous close), per the latest update on this page.
What is the P/E ratio of Sun Pharmaceutical Industries Ltd.?
SUNPHARMA (Sun Pharmaceutical Industries Ltd.) has a trailing twelve-month P/E ratio of 35.7.
What is the market cap of Sun Pharmaceutical Industries Ltd.?
SUNPHARMA has a market capitalisation of approximately ₹426,002 crore.
Is SUNPHARMA near its 52-week high?
SUNPHARMA is trading -13.0% from its 52-week high of ₹2,046.90 as of 2026-10-07.
What is the RSI of SUNPHARMA?
The 14-day RSI of SUNPHARMA is 36.4, which is considered neutral.
Is SUNPHARMA above its 200-day moving average?
SUNPHARMA is trading below its 200-DMA of ₹1,809.59 (-1.6% away).
What is the F&O buildup in SUNPHARMA?
The latest end-of-day derivatives data classifies SUNPHARMA as Neutral (bias: neutral), based on the day's combined price and open-interest change.
What is the max pain and PCR for SUNPHARMA options?
SUNPHARMA's option-chain max pain strike is ₹1,820 and its put-call ratio (OI) is 0.76, from the latest end-of-day option chain.
Are FIIs or big investors buying SUNPHARMA?
Strota tracks every bulk and block deal in SUNPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.